Living with treatment-related hearing loss: Experiences of survivors of childhood brain cancer
Living with treatment-related hearing loss: Experiences of survivors of childhood brain cancer
We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Living with treatment-related hearing loss: Experiences of survivors of childhood brain cancer
Understanding treatment decision-making processes in families where a child or young person has relapsed/refractory rhabdomyosarcoma
MG-fnRMS and CINSARC gene expression signatures to predict relapse in fusion gene negative rhabdomyosarcomas: assessing an approach to improve patient outcomes
An open label, single centre, single arm, prospective feasibility study evaluating the effectiveness of near-infrared fluorescence(NIRF)using indo-cyanine green(ICG)in intra-abdominal or intra-thoracic minimally invasive surgery(MIS)in paediatric oncology.
Deciphering the genomic landscape of childhood refractory t-cell acute lymphoblastic leukaemia
Optimising tyrosine kinase inhibitor therapy in newly diagnosed metastatic Ewing sarcoma
Novel biomarkers for PARP inhibitor trials for children with cancer
Enhancing CAR T-cell expansion and prolonged persistence for the effective treatment of paediatric medulloblastoma
The Role of Cut-and-Run, an Aberrant V(D)J Recombination Reaction, in the Development of Acute Lymphoblastic Leukaemias with Poor Prognosis